Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel. [electronic resource]
Producer: 20030121Description: 2413-22 p. digitalISSN:- 1078-0432
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis -- drug effects
- Blotting, Northern
- Cell Division -- drug effects
- Drug Synergism
- Endothelial Growth Factors -- metabolism
- Female
- Fibroblast Growth Factor 2 -- metabolism
- Fluorescent Antibody Technique
- Humans
- Immunoenzyme Techniques
- In Situ Nick-End Labeling
- Intercellular Signaling Peptides and Proteins -- metabolism
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Interleukin-8 -- metabolism
- Lymphokines -- metabolism
- Matrix Metalloproteinase 9 -- metabolism
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Platelet Endothelial Cell Adhesion Molecule-1 -- metabolism
- Polyethylene Glycols
- Proliferating Cell Nuclear Antigen -- metabolism
- Recombinant Proteins
- Tumor Cells, Cultured
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.